Full View

Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and …

AWY Chung, HHC Yang, MW Radomski… - Circulation …, 2008 - Am Heart Assoc
β-Blockers, eg, atenolol, are the cornerstone therapy for thoracic aortic aneurysm (TAA) in
patients with Marfan syndrome; however, continued aortic dilatation has been reported. We …
被引用次数：287 相关文章

Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and …

AW Chung, HH Yang, MW Radomski… - Circulation …, 2008 - europepmc.org
Beta-blockers, eg, atenolol, are the cornerstone therapy for thoracic aortic aneurysm (TAA)
in patients with Marfan syndrome; however, continued aortic dilatation has been reported …

Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and …

AWY Chung, HHC Yang, MW Radomski… - Circulation …, 2008 - pubmed.ncbi.nlm.nih.gov
Beta-blockers, eg, atenolol, are the cornerstone therapy for thoracic aortic aneurysm (TAA)
in patients with Marfan syndrome; however, continued aortic dilatation has been reported …

Long-Term Doxycycline Is More Effective Than Atenolol to Prevent Thoracic Aortic Aneurysm in Marfan Syndrome Through the Inhibition of Matrix Metalloproteinase-2 …

AWY Chung, HHC Yang, MW Radomski… - Circulation …, 2008 - cir.nii.ac.jp
抄録< jats: p> β-Blockers, eg, atenolol, are the cornerstone therapy for thoracic aortic
aneurysm (TAA) in patients with Marfan syndrome; however, continued aortic dilatation has …